09:50 AM EST - Medicenna Therapeutics Corp. : Will present two abstracts, both as oral presentations, at the Promise of Interleukin-2 Therapy Conference, taking place at the Centre International de Conférences Sorbonne Université in Paris, from September 4-7. Medicenna Therapeutics Corp.
shares T.MDNA are trading down $0.01 at $2.15.
